Wong, S.; Brown, A.D.; Abrahams, A.B.; Nurzak, A.N.; Eltaher, H.M.; Sykes, D.A.; Veprintsev, D.B.; Fone, K.C.F.; Dixon, J.E.; King, M.V.
A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro. Pharmaceutics 2024, 16, 1267.
https://doi.org/10.3390/pharmaceutics16101267
AMA Style
Wong S, Brown AD, Abrahams AB, Nurzak AN, Eltaher HM, Sykes DA, Veprintsev DB, Fone KCF, Dixon JE, King MV.
A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro. Pharmaceutics. 2024; 16(10):1267.
https://doi.org/10.3390/pharmaceutics16101267
Chicago/Turabian Style
Wong, Sara, Alexander D. Brown, Abigail B. Abrahams, An Nisaa Nurzak, Hoda M. Eltaher, David A. Sykes, Dmitry B. Veprintsev, Kevin C. F. Fone, James E. Dixon, and Madeleine V. King.
2024. "A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro" Pharmaceutics 16, no. 10: 1267.
https://doi.org/10.3390/pharmaceutics16101267
APA Style
Wong, S., Brown, A. D., Abrahams, A. B., Nurzak, A. N., Eltaher, H. M., Sykes, D. A., Veprintsev, D. B., Fone, K. C. F., Dixon, J. E., & King, M. V.
(2024). A Modified Cell-Penetrating Peptide Enhances Insulin and Oxytocin Delivery across an RPMI 2650 Nasal Epithelial Cell Barrier In Vitro. Pharmaceutics, 16(10), 1267.
https://doi.org/10.3390/pharmaceutics16101267
